Faculty
Shailender Bhatia, MD
Assistant Professor
Department of Medicine
Division of Oncology
Mailing Address
Seattle Cancer Care Alliance
825 Eastlake Ave E
Seattle, WA 98109
Admin Contact
Sandra Bergevin
206.288.7341
Specialty / Expertise
Skin Cancers (Melanoma, Merkel Cell Cancer)
Kidney Cancers
Research Interests
Clinical trials in Melanoma, Renal Cell Cancers
Immunotherapy
Targeted Therapies
Current Research Projects
N/A
Training
Dr. Bhatia received his MD from All India Institute of Medical Sciences, New Delhi, India. He completed his Internal Medicine Residency at the University of Connecticut Health Center, Farmington CT. He was a Post-Doctoral Fellow in Hematology-Oncology at the University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA.
Selected Publications
Bhatia S, Huber BR, Upton MP, Thompson JA. Inflammatory enteric neuropathy with severe constipation after ipilimumab treatment for melanoma. J Immunotherapy, 2008 in press.
Thompson JA, Curti BD, Redman BG, Bhatia S, Weber JS, Agarwala SS, Sievers EL, Hughes SD, Devries TA, Hausman DF. Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma. J Clin Oncol 2008 Apr 20;26(12):2034-2039.
Mann GN, Bhatia S, Thompson JA. Anorectal Melanoma. Gastrointestinal Oncology: A Critical MDT Approach, 2008 May.
Bhatia S, Curti BC, Gordon M, Quinn D, DeVries TA, Hunder N, Hausman DF, Thompson JA. Recombinant IL-21 in combination with sorafenib: Interim results from a phase I/II study in patients with metastatic renal cell cancer. 2008 ASCO
Bhatia S, Bauer F, Bilgrami S. Candidiasis - Associated Hemophagocyctic Lymphohistiocytosis in Patient Infected with Human Immunodeficiency Virus. Clin Infect Dis 2003 Dec 1;37(11):e161-6.
Last updated: Oct 2011